• Abstracts are required for all presentations.
• Abstracts must be submitted maximum by Tuesday, 30 April 2024 (23:59 GMT).
• Abstracts must be submitted in English.
• It is possible to withdraw an abstract within 14 days from notification on acceptance mail, through a withdrawal of abstracts notification in writing.
• If selected, it is the responsibility of the presenter to bear his travel and accommodation expenses.
• An Oral Abstracts submission when not accepted for Oral Presentation are provided the opportunity to present it as a Poster. The presenter may either accept to present it as a poster or withdraw their abstract if not applicable to present as a poster.

• Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.
• Disclosure: Abstract submitter and presenter are required to disclose any conflict of interest.
• Ensure that all co-authors approve the abstract submission, publication, and potential presentation.
• All approved presenters will be registered to the congress. Only 1 abstract presenter will receive free registration for each accepted abstract to attend the congress. Any additional presenters or co-authors for the same abstract should register themselves to attend the congress.
• Abstract submitters must consent to the policies of Abstract Submission.
• Scientific committee reserves the right to exclude any abstract from the scientific program that does not follow appropriate guidelines as mentioned.

Original works and Case Reports about Dermatology & Aesthetic Medicine will be accepted.

The abstract text body is limited to 3,000 characters (Approx. 500 words) including spaces. (Please do not include the title and the author’s information in the text body (names and affiliations), this information will be required in the web form).

The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS.

No full stop at the end.

There are no limitations on the number of abstracts that an individual can submit. However, one individual can only present a maximum of 2 abstract (independent of the format) during the entire conference. If you have more than 2 abstracts accepted, you will be obliged to identify alternate presenters for any abstract above the first two.

The abstract must include the following:

All abbreviations must be defined in first use.

No identifying features such as names of authors, hospitals, medical schools, clinics or cities may be listed in the title or abstract text, as a “blind” review process will be used. You will be asked to enter the name(s) of author(s) and their institution(s), when you submit your abstract online.

Statements such as “results will be discussed” or “data will be presented” cannot be accepted.

Use of brand names for all references to products or companies, generic names must be used. The brand name can be inserted as a reference at the bottom of the abstract page. Papers containing brand names/company names in the abstract text (i.e. not in a reference at the bottom of the page) may be rejected for this reason only. scientific committee reserves the right to replace any brand name with a generic name without further notice.

Images that are uploaded to follow the abstract are not guaranteed inclusion in the congress materials.